Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Health

CVC case study: Saint-Gobain NOVA is organised by geography

Each team member will do every part of the process, from scouting, selection to presenting ideas to the business units.


Jun 15, 2022

CVC case study: How TDK Ventures' young team grew

TDK Ventures started with a minimal team size while it was proving itself and grew it when the portfolio needed more support.

Jun 15, 2022

CVC case study: Capita Scaling Partner's equity-for-services model

Capita Scaling Partner's equity-for-services model needs a team of 28, most focusing on finding synergies between the parent and the startup.

Jun 15, 2022

What is the ideal size for a CVC team?

The short answer is: “It depends” (on strategy, focus and structure). A quick rule of thumb is 3 people per $100m in the fund.

Jun 15, 2022

Daily Deal Round Up: June 14, 2022

Qualcomm bought portfolio company Cellwize for $350m while Northrop Grumman took part in a $135m round for radar technology producer Echodyne.

Jun 14, 2022

Daily Deal Round Up: June 13, 2022

SR One co-led antibody therapy developer Ancora Biotech's $60m series A round while Al-Dhow Engineering helped coffee chain Flash Coffee secure $32.8m.

Jun 13, 2022

Healthcare: what next after a bumper year?

The healthcare sector had a record year for investment in 2021 and corporate-backed rounds rose more than 50%, to a record high of $30.51bn.

Jun 13, 2022

Daily Deal Round Up: June 10, 2022

American Family helped digital auto insurance portal Branch secure $147m while Anthem, Optum and CVS Health all contributed to a $140m round for home care platform developer CareBridge.

Jun 10, 2022

Rockett takes off from Kaiser Permanente

Liz Rockett has departed from the healthcare group’s Kaiser Permanente Ventures unit, following in the footsteps of former senior team members Amy Belt Raimundo and Sam Brasch.

Jun 10, 2022

Daily Deal Round Up: June 9, 2022

GV participated in tech apprenticeship platform Multiverse’s $220m series D round while Amgen, UCB, UPMC and Takeda helped genetics disease drug developer Code Biotherapeutics raise $75m.

Jun 9, 2022

Australian investors in 'significant pullback'

GCV has spoken to several corporate and VC investors about the recent hit to Australia's startup scene following a post-lockdown deal surge.

Jun 9, 2022

Purpose-driven startups fail less and raise more

It pays to invest in these companies. Research shows they are less likely to fail and will attract two to three times more investment.

Jun 9, 2022
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here